– CANADA, Mississauga – Crescita Therapeutics Inc. (TSX: CTX), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, today announced that Samira Sakhia, President of Knight Therapeutics (TSX: GUD), has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms. Sakhia holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy and Marketing from McGill University and is a Chartered Professional Accountant.

Dr. Henrich Guntermann and Mr. Klaus von Lindeiner have tendered their resignations as board members of the Company.

“On behalf of the board and management team, I would like to thank Dr. Guntermann and Mr. von Lindeiner for their contributions to Nuvo Research and most recently to Crescita,” said Dan Chicoine, Crescita’s Executive Chairman. “We are pleased that Ms. Sakhia has joined the Crescita board of directors. Her knowledge and experience in the pharmaceutical industry will benefit the Company as we move towards our goal of becoming a dominant player in the Canadian and U.S. skin care industry.”

About Crescita Therapeutics Inc.

Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita’s board of directors and management team have demonstrated success in building Crescita’s predecessor company, Nuvo Research Inc., including developing multiple drugs that are now approved and commercialized and negotiating multiple licensing transactions.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>

Comments are closed.